Morgellons disease is a skin condition characterized by slow-healing sores and unusual filaments, often multicolored, that appear under, embedded in, or projecting from the skin. People with the condition frequently report crawling, stinging, or biting sensations on or beneath the skin’s surface. It affects roughly 3.65 people per 100,000, predominantly women and people over 50, and remains one of the most contentious diagnoses in modern medicine.
Core Symptoms
The hallmark of Morgellons is the appearance of spontaneous ulcerative skin lesions containing microscopic filaments. These filaments visually resemble tiny textile fibers and come in white, black, red, or blue. They can lie beneath the skin, sit embedded within it, or poke through the surface. The sores tend to heal slowly and may appear across different parts of the body over time.
Beyond the skin lesions, many people experience formication, a sensation of insects crawling, stinging, or biting the skin even when nothing is there. This symptom alone is not unique to Morgellons. Formication is a recognized feature of peripheral neuropathy and shows up in conditions ranging from diabetes and multiple sclerosis to menopause and chronic infections.
What often surprises people is that Morgellons doesn’t stop at the skin. Many patients report systemic symptoms: persistent fatigue, joint pain, cognitive difficulties sometimes described as “brain fog,” nerve pain, and even cardiac complications. This symptom profile overlaps significantly with Lyme disease, which has become central to the scientific debate over the condition’s cause.
The Debate: Psychiatric Disorder or Infection?
Most medical practitioners still classify Morgellons as a delusional disorder, specifically a form of delusional parasitosis, where a person believes they are infested with bugs or parasites. A major 2012 study conducted through the CDC and Kaiser Permanente Northern California examined 115 patients and found that most materials collected from participants’ skin were composed of cellulose, likely cotton fibers from clothing or the environment. The study found no common underlying medical condition or infectious cause, and no geographic clustering of cases.
That interpretation has been challenged by a separate line of research linking Morgellons to Lyme disease. Histological studies have shown that the filaments in Morgellons lesions are composed of collagen and keratin, both human proteins produced by skin cells. Testing with a specialized stain called calcofluor-white confirmed the filaments are not cellulose (the material found in cotton or plant-based textiles) and not chitin (found in insect exoskeletons or fungal cells). In other words, the filaments appear to be generated by the body itself, not picked up from the environment.
A study of 25 Morgellons patients used culture, microscopy, immune staining, and genetic testing to look for spirochetes, the corkscrew-shaped bacteria that cause Lyme disease. Spirochetes identified as Borrelia strains were detected in 24 of the 25 patients. In some cases, Borrelia burgdorferi (the primary Lyme disease species) was cultured from blood and even vaginal secretions, demonstrating active, systemic infection. Other Borrelia species were also found. Researchers in this camp argue that Morgellons represents a specific skin manifestation of Lyme borreliosis in a subset of patients.
This disagreement is not just academic. It directly shapes whether a patient receives psychiatric medication, antibiotics, or both, and it profoundly affects how they are treated by their doctors.
Who Gets Morgellons
In the CDC-affiliated study, the median age of patients was 52. Seventy-seven percent were female, and the same percentage were white. Cases were spread across a 13-county region in Northern California with no geographic clustering, suggesting the condition isn’t linked to a localized environmental exposure.
Psychiatric comorbidities are common. In self-reported surveys of Morgellons patients, 52% reported significant anxiety, about 42% reported depression, and 81% described poor overall quality of life tied to pain. Whether these psychiatric conditions contribute to the disease, result from it, or simply coexist alongside it remains unclear. Fatigue and joint pain, for instance, are common symptoms of both depression and chronic infection, making it difficult to untangle cause from effect.
How It’s Treated
Treatment depends largely on which explanation a clinician favors. On the psychiatric side, antipsychotic medications have shown some success in small trials. One study found that 63% of patients (15 out of 24) achieved partial or full remission of symptoms after about 6.6 months on an antipsychotic. Other medications in the same class have similarly reduced itching, anxiety, and the skin-picking behavior that worsens lesions.
On the infectious side, antibiotics targeting Lyme disease have been used with reported benefit in individual cases. In one published case report, a patient who had not improved on antipsychotic medications was started on a two-week course of doxycycline, an antibiotic commonly used for Lyme disease, and experienced symptom improvement. No large-scale clinical trials have yet established a standard antibiotic regimen for Morgellons specifically.
Some patients receive both approaches simultaneously. The case report patient, for example, continued her antipsychotic medications while adding the antibiotic course.
The Challenge of Getting a Diagnosis
One of the most difficult aspects of Morgellons is the patient-physician dynamic. Because most doctors view the condition as delusional, patients often feel dismissed or disbelieved, which erodes trust and can lead them to avoid medical care altogether. Experts in psychodermatology (the overlap of skin and mental health conditions) emphasize that doctors should validate a patient’s experience and suffering without necessarily agreeing on the specific cause. The recommended approach is to shift the conversation away from debating the exact origin of the symptoms and toward a shared goal: reducing pain, healing the skin, and improving quality of life.
For people living with Morgellons, this means finding a provider willing to take the symptoms seriously, investigate underlying conditions like Lyme disease or peripheral neuropathy, and work through treatment options methodically rather than defaulting to a single explanation.